Abstract:Amyloid- β peptides (Aβ) participate in the development of Alzheimer's disease (AD). AD brains accumulate multiple forms of Aβ peptides, composed of Aβ(1–40/42) with pyroglutamate-Aβ(3–40/42) (pGlu-A β) present as a major portion of Aβ. Several studies estimate that pGlu-A β comprises approximately 50% or more of total A β (Saido et al., 1995; Kuo et al., 1997). The pGlu-Aβ(3–40/42) is hypothesized to facilitate the oligomerization of Aβ(1–40/42) (Schilling et al., 2006) to result in neurotoxicity. The formation of pGlu-Aβ(3–40/42) is produced from the substrate Aβ(3–40/42), which may be generated by a beta-secretase-dependent or -independent mechanism. Cathepsin B has been shown to generate A β(1–40/42) from AD mice expressing APP with the wild-type beta-secretase site (Kindy et al., 2012) expressed in the majority of AD patients. This study, therefore, addresses the role of cathepsin B, possessing wild-type beta-secretase function, in producing pGlu-Aβ(3–40/42). Knockout of the cathepsin B gene was conducted in the APP/Lon mouse model of AD. The APP/Lon mice were also treated with E64d, inhibitor of cathepsin B, by oral administration. Brains were then assessed for levels of pGlu-Aβ(3–40/42) and Aβ(1–40/42), amyloid plaque; animals were evaluated for memory function by the Morris water maze test. Knockout of the cathepsin B gene in the APP/Lon AD mouse model, expressing APP with the wild-type beta-secretase site, was assessed. Knockout of the cathepsin gene resulted in a significant reduction in brain pGlu-Aβ(3–40/42) as well as Aβ(1–40/42). Chemical inhibition of cathepsin B, conducted by oral administration of the E64d inhibitor, in the APP/Lon mice reduced brain pGlu-Aβ(3–40/42) and Aβ(1–40/42). Also, cathepsin B inhibition and gene knockout reduced brain amyloid plaque accumulation and improved memory function in the APP/Lon mice. Cellular studies show that pGlu-Aβ(3–40) is secreted from the regulated secretory pathway of neuronal-like chromaffin cells, and inhibition of cathepsin B (with CA074Me) reduces pGlu-A β(3–40). Results from knockout of the cathepsin B gene in the APP/Lon AD mouse model show that cathepsin B participates in the production of pGlu-Aβ(3–40/42), as well as A β(1–40/42). Cathepsin B inhibitors will likely be effective at reducing neurotoxic pGlu-Aβ(3–40/42), as well as Aβ(1–40/42), for improvement of memory function in AD.

Distribution and Expression of Pen-2 in the Central Nervous System of APP/PS1 Double Transgenic Mice.

Identifying PEN-2-interacting Proteins by Yeast Two-hybrid

Neuron‐specific Deletion of Presenilin Enhancer2 Causes Progressive Astrogliosis and Age‐related Neurodegeneration in the Cortex Independent of the Notch Signaling

Pen2 And Presenilin-1 Modulate The Dynamic Equilibrium Of Presenilin-1 And Presenilin-2 Gamma-Secretase Complexes

PEN-2 and APH-1 Coordinately Regulate Proteolytic Processing of Presenilin 1

Pen-2 Enhances Gamma-Cleavage after Presenilin Heterodimer Formation

P1–298: Differential Transcriptional Regulation of PEN–2 and APH–1A, Two Key Components of the Gamma–secretase Complex

P53-Dependent Control of Transactivation of the Pen2 Promoter by Presenilins

Pen-2 is dispensable for endoproteolysis of presenilin 1, and nicastrin-Aph subcomplex is important for both γ-secretase assembly and substrate recruitment.

Transcriptional Regulation of PEN-2, a Key Component of the Γ-Secretase Complex, by CREB

Presenilins and γ-Secretase Inhibitors Affect Intracellular Trafficking and Cell Surface Localization of the γ-Secretase Complex Components

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2.

Genetic Dissection of Γ-Secretase-dependent And-Independent Functions of Presenilin in Regulating Neuronal Cell Cycle and Cell Death

Differential expression and modulation of presenilin-1 and presenilin-2 in neural cell lines

O1–08–02: Cathepsin B Produces Brain Pyro‐glu‐beta‐amyloid in a Transgenic Alzheimer's Disease Mouse Model

Presenilin/Gamma-Secretase-Dependent Processing Of Beta-Amyloid Precursor Protein Regulates Egf Receptor Expression

A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface.

Intracellular Trafficking of Presenilin 1 Is Regulated by β-Amyloid Precursor Protein and Phospholipase D1

A novel mouse model for N-terminal truncated Aβ2-x generation through meprin β overexpression in astrocytes